Endurant Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-55,540
Closed -$1.56M 70
2021
Q1
$1.56M Sell
55,540
-151,753
-73% -$4.26M 0.41% 51
2020
Q4
$5.39M Buy
207,293
+71,392
+53% +$1.86M 1.94% 23
2020
Q3
$5.05M Sell
135,901
-47,348
-26% -$1.76M 1.49% 18
2020
Q2
$9.4M Buy
+183,249
New +$9.4M 0.52% 7